Fezagepras sodium - ≥99% , CAS No.1254472-97-3

CAS: 1254472-97-3 Cat. No.: F650207 Molecular Weight: 228.26 EC Number: 879-954-2 PubChem CID: 46944243
AVAILABLE TO ORDER
GRADE & PURITY ≥99%
Synonyms
R05571KE07 | SB17465 | PBI-4050 (sodium) | SCHEMBL19095288 | 1254472-97-3 (sodium) | 1254472-97-3 | UNII-R05571KE07 | HY-100775 | BDBM50556782 | Setogepram sodium | PBI-4050 sodium | sodium 2-(3-pentylphenyl)acetate | sodium;2-(3-pentylphenyl)acetate | Be
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
5mg
F650207-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$360.90
10mg
F650207-10mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$580.90
50mg
F650207-50mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,800.90
100mg
F650207-100mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$2,700.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥99% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C,Desiccated Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 Fezagepras sodium decreases renal, liver and pancreatic fibrosis Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .

In Vitro

Fezagepras sodium (500 μM; 24 hours) inhibits TGF-β (10 ng/mL)-activated human hepatic stellate cells (HSCs) proliferation. ?\nFezagepras sodium (250 or 500 μM; 24 hours) dose-dependently arrests HSCs at the G0/G1 phase without inducing apoptosis. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: HSCs Concentration: 250 or 500 µM Incubation Time: 24 hours Result: Inhibited TGF-β-activated HSC proliferation. TGF-β (10 ng/mL) increased HSC proliferation by 10%. Cell Cycle AnalysisCell Line: HSCs Concentration: 250 µM, 500 µM Incubation Time: 24 hours Result: Inhibited cell cycle progression.

In Vivo

Fezagepras sodium (100 mg/kg/day; gavage from 8-20 weeks of age) markedly decreases hyperglycemia and markedly improvea glucose tolerance in type 2 diabetes eNOS -/- db/db mice .· MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Type 2 diabetes eNOS -/- db/db mice Dosage: 100 mg/kg/day Administration: Given via daily gavage from 8-20 weeks Result: Compared with vehicle-treated mice, hyperglycemia was markedly decreased, and glucose tolerance was markedly improved.

Form:Solid

IC50& Target:GPR40, GPR84

Specifications

Synonyms
R05571KE07 | SB17465 | PBI-4050 (sodium) | SCHEMBL19095288 | 1254472-97-3 (sodium) | 1254472-97-3 | UNII-R05571KE07 | HY-100775 | BDBM50556782 | Setogepram sodium | PBI-4050 sodium | sodium 2-(3-pentylphenyl)acetate | sodium;2-(3-pentylphenyl)acetate | Be
Specifications & Purity
≥99%
Biochemical and Physiological Mechanisms
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Fezagepras sodium decreases renal, liver and pancreatic fibrosis. Fezagepras sodium exerts anti-fibrotic, anti-infla
Storage
Store at 2-8°C, Desiccated
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
AGONIST
Purity
≥99%
Names and Identifiers
Canonical SmilesCCCCCC1=CC(=CC=C1)CC(=O)[O-].[Na+]
IUPAC Namesodium;2-(3-pentylphenyl)acetate
InChIKeyCNSJWSLXKSJQFE-UHFFFAOYSA-M
INCHI1S/C13H18O2.Na/c1-2-3-4-6-11-7-5-8-12(9-11)10-13(14)15;/h5,7-9H,2-4,6,10H2,1H3,(H,14,15);/q;+1/p-1
Isomeric SMILES CCCCCC1=CC(=CC=C1)CC(=O)[O-].[Na+]
Alternate CAS 1254472-97-3
PubChem CID 46944243
Molecular Weight 228.26

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentBenzene and substituted derivatives
Alternative Parents Carboxylic acid salts  Monocarboxylic acids and derivatives  Carboxylic acids  Organic sodium salts  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  Organic cations  
Molecular FrameworkAromatic homomonocyclic compounds
Substituents Monocyclic benzene moiety - Carboxylic acid salt - Organic alkali metal salt - Monocarboxylic acid or derivatives - Carboxylic acid - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organic sodium salt - Organic salt - Organooxygen compound - Carbonyl group - Organic cation - Aromatic homomonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilityH2O : ≥ 100 mg/mL (438.10 mM) DMSO : ≥ 64 mg/mL (280.38 mM)
Molecular Weight228.260 g/mol
XLogP3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count6
Exact Mass228.113 Da
Monoisotopic Mass228.113 Da
Topological Polar Surface Area40.100 Ų
Heavy Atom Count16
Formal Charge0
Complexity194.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count2
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.